Kevin Espinoza
Director, Ethics & Compliance
North American Pharma, GSK

Kevin has 10 years of commercial and compliance experience at large and mid-size pharma companies. At Eli Lilly and Company, Kevin held roles in hospital specialty sales, corporate branding, global marketing. Kevin introduced and managed Lilly's international compliance program, which was fully integrated into Lilly's global sales and marketing organization. After four years of compliance management at Lilly, Kevin joined Stiefel Laboratories in January of 2008. At Stiefel, Kevin introduced Stiefel's international compliance and anti-corruption program. Following, GSK's acquisition of Stiefel laboratories in 2009, Kevin was retained by GlaxoSmithKline as Stiefel's Global Compliance Officer, overseeing the compliance program for the US and all international geographies. In March of 2010, Kevin became GSK's Deputy Compliance Officer for North America Pharma. At GSK, Kevin spends the majority of his time collaborating with commercial teams to develop compliant business solutions.